Senetek PLC

62 articles about Senetek PLC

• Senetek PLC Reports 2009 Financial Results

  4/16/2010

• Senetek PLC Embarks on New Strategic Direction; Company Completes $3.0 Million Financing; CEO and CFO Terminated in Connection with Financing

  3/11/2010

• Senetek PLC Announces 2009 Annual General Meeting Voting Results

  12/16/2009

• Senetek PLC Reports Third Quarter 2009 Financial Results

  11/17/2009

• Senetek PLC Implements New Corporate Communication Policy

  10/21/2009

• Senetek PLC Release: New PyratineXR(TM) Offers Hope for 14 Million-Plus Rosacea Sufferers and Others with Facial Redness

  7/22/2009

• Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany

  6/8/2009

• Senetek PLC Reports 2008 Financial Results

  4/1/2009

• Senetek PLC Announces New Investor Communication Hotline

  4/1/2009

• Senetek PLC Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers

  3/5/2009

• Senetek PLC Pyratine-XR(TM) Study to be Presented at South Beach Symposium

  2/12/2009

• Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology

  12/15/2008

• Senetek PLC Reports Third Quarter 2008 Financial Results

  11/17/2008

• Senetek PLC Affirms Strong Financial Position $16 Million Cash On Hand and No Debt

  10/13/2008

• Senetek PLC Reports Second Quarter 2008 Financial Results Cash on Hand Totals $17.8 million at June 30 Investor Conference Call Scheduled for September 5

  8/15/2008

• Senetek PLC Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Ltd.

  7/3/2008

• Senetek PLC Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma

  7/1/2008

• Senetek PLC Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM)

  7/1/2008

• Senetek PLC Announces Key Personnel Appointments Phillip Rose Named Chief Operating Officer

  6/10/2008

• Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea

  5/6/2008